Godavari Biorefineries logo

Godavari Biorefineries financials and balance sheet

NSE: GODAVARIBBSE: 544279Diversified FMCGSmall Cap

Last close ₹205.63down ₹16.79 (7.55%)BSE ₹206.30

Share price at the NSE close on 23 Oct 2026. Previous close ₹222.42.

52-week range of traded prices to 23 Oct 2026
₹197.32Low, 23 Oct 2026₹353.00High, 24 Apr 2026
Market cap
₹1,052 Cr1,282nd largest listed
P/E
4,670.8
P/E without one-offs
33.6
P/B
1.3
Dividend yield
Nonein the last 12 months
ROE
0.0%
ROE without one-offs
4.0%
ROCE
5.0%
Debt to equity
0.67
Volume, NSE
3,31,57735.0% delivered

2 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Godavari Biorefineries annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹1,988 Cr, year to Mar 2026Back to profit in the year to Mar 2026, ₹3.53 Cr

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,988
  2. Materials and goods−1,427
  3. Employee costs−135
  4. Other expenses−299
  5. Operating profit127
  6. Depreciation−54
  7. Other income+12
  8. One-off items−31
  9. Finance costs−49
  10. Profit before tax4.6
  11. Tax−1.0
  12. Net profit3.5

What the company owns

  • Plant, investments and other assets₹1,131 Cr
  • Inventory₹776 Cr
  • Receivables₹114 Cr
  • Cash and bank₹32 Cr

What pays for it: net worth and liabilities

  • Net worth₹788 Cr
  • Owed to suppliers₹569 Cr
  • Borrowings₹530 Cr
  • Other liabilities₹165 Cr

Godavari Biorefineries business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Consolidated, ₹ crore, as the company reports them. A segment at a loss has no share of profit.Godavari Biorefineries segment results by quarter

Revenue by segment

₹2,681 CrTotal
  • Sugar₹1,279 Cr47.7% of total
  • Distlliery₹664 Cr24.8% of total
  • Bio Based Chemicals₹578 Cr21.6% of total
  • Cogeneration₹160 Cr6.0% of total

Profit by segment

  • Sugar₹23.0 Cr33.5% of total
  • Distlliery₹9.5 Cr13.8% of total
  • Bio Based Chemicals₹36.3 Cr52.8% of total

Segment results by year

Consolidated, ₹ crore, years to March.

  • Sugar

    Revenue, ₹ crore
    Profit, ₹ crore
  • Distlliery

    Revenue, ₹ crore
    Profit, ₹ crore
  • Bio Based Chemicals

    Revenue, ₹ crore
    Profit, ₹ crore
  • Cogeneration

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2025Mar 2026
Revenue of all businesses2,6122,681
Company revenue, as in its results1,8701,988
Revenue1,3131,279
Revenue growth–−2.6%
Profit2623
Profit growth–−11.0%
Margin2.0%1.8%
Return on capital1,388.7%–
Assets783796
Liabilities781828
Capital employed2−32
Revenue594664
Revenue542578
Revenue162160
Revenue2027
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Consolidated, ₹ crore, years to March.Godavari Biorefineries quarterly results

₹ croreMar 2025Filed 10 JunMar 2026Filed 22 May
Revenue from operations1,8701,988
1,7671,861
Materials and goods bought1,3851,427
Employee costs125135
Other expenses256299
Operating profit before depreciation104127
Operating margin5.5%6.4%
Materials, % of revenue74.1%71.8%
Employee costs, % of revenue6.7%6.8%
Other expenses, % of revenue13.7%15.0%
Depreciation and amortisation5054
Operating profit after depreciation5473
Other income1712
Finance costs7249
Profit before one-off items and tax−236
One-off items0−31
Profit before tax−25
221
Net profit−234
Other comprehensive income01
Total comprehensive income−244
Net margin−1.3%0.2%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2025Filed 10 JunMar 2026Filed 22 May
782788
Share capital5151
Reserves731737
489530
884874
289390
Total assets1,9552,052
9321,061
1,023992
Net debt458498
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2025Filed 10 JunMar 2026Filed 22 May
6171
6172
−10669
Receivables5534
Inventories65−36
Payables−9935
Other working capital−12836
Tax paid0−1
Capital spending71169
Free cash flow−652
−69−163
64−6
Dividends paid00
Shares bought back00
Shares issued3052
Net change in cash13
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2025Filed 10 JunMar 2026Filed 22 May
Earnings per share−₹5.11₹0.69
Diluted earnings per share−₹5.11₹0.69
Book value per share₹152.80₹154.03
Shareholder yield−40.4%−0.1%
Market cap at the year end (₹ crore)7541,511

Ratios

Consolidated, years to March.Godavari Biorefineries PE ratio and valuation

RatioMar 2025Filed 10 JunMar 2026Filed 22 May
Revenue growth–6.3%
Operating profit growth–22.6%
−3.0%0.4%
–3.4 pts
From the net margin–3.4 pts
From asset turnover–0.0 pts
From borrowing–0.0 pts
Return on capital employed4.2%5.5%
Cash conversion–4,856.2%
Interest cover0.71.5
Debt to equity0.630.67
Receivable days2721
Inventory days195198
Payable days140146
Cash conversion cycle, days8274
Working capital days7052
Asset turnover0.960.99
Assets per rupee of net worth2.502.55
Sales per rupee of plant2.172.30
Capital spending to depreciation1.423.10
Plant being built, % of plant in use2.6%15.0%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
0.2%
Cash from operations against operating profit
134.8%
Measure3 years
Return on equity, average−1.3%
Return on capital employed, average4.9%
Operating margin, average6.0%
Net margin, average−0.5%
Asset turnover, average0.97
Cash conversion cycle, days, average78
Interest cover, average1.1
Debt to equity, average0.65

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations171
Cash from investing−163
Cash from financing−6
Capital spending169
Dividends paid0
Shares bought back0
Shares issued for cash2
Borrowings raised144
Borrowings repaid102

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2025Mar 2026
Altman Z-scorePublished threshold 1.812.072.34
Beneish M-scorePublished threshold −1.78–−2.40
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–−0.26
Receivables growth less revenue growthOur threshold 0 percentage points–−24.11
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–1.89
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–−2.21
Assets under construction, years of additionsOur threshold 2 years of additions–2.27
Effective tax ratePublished threshold 17.16 per cent–22.75
Tax charged less tax paid, % of profitOur threshold 10 percentage points–−2.13
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
17 Mar 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT-Cash CreditCARE BBB+Review, Re-affirmStable276
17 Mar 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT-Term LoanCARE BBB+Review, Re-affirmStable377.83
17 Mar 2026CARE Ratings Limited (opens in a new tab)Non-fund-based - ST-BG/LCCARE A2Review, Re-affirm97
17 Mar 2026CARE Ratings Limited (opens in a new tab)Fixed DepositCARE BBB+Review, Re-affirmStable85
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.